Insmed Narrows Q3 Loss to $100.32 Million as Revenue Jumps 268%

Insmed Inc. (INSM) reported a third-quarter loss of $100.32 million, or $0.46 per share, sharply narrower than the $370.02 million, or $1.75 per share, loss recorded a year earlier. Revenue for the period rose 268.4% to $524.43 million from $142.34 million last year, according to the company's GAAP results. The results reflect the biopharmaceutical company's swing toward profitability on the top line, with the reduced net loss driven by the tripling of quarterly revenue.